Pituitary adenylate cyclase-activating polypeptide (PACAP) receptor 1 (PAC1R, ADCYAP1R1) neurons express the PAC1 receptor, a G protein-coupled receptor that binds both PACAP and vasoactive intestinal peptide (VIP). PAC1R is a critical neuropeptide receptor involved in neuroprotection, synaptic plasticity, circadian rhythm regulation, and stress responses throughout the central nervous system.
¶ Gene and Receptor Structure
The ADCYAP1R1 gene (located on chromosome 7p14) encodes the PAC1 receptor, a class B GPCR with:
- Extracellular N-terminal domain: Contains PACAP/VIP binding site
- Seven transmembrane domains: G protein coupling
- Intracellular loops: Signal transduction machinery
- C-terminal tail: Phosphorylation sites for desensitization
¶ Ligand Specificity
| Ligand |
Affinity (nM) |
Receptor Subtype |
| PACAP-38 |
0.1-0.5 |
PAC1R > VPAC1R > VPAC2R |
| PACAP-27 |
0.2-0.8 |
PAC1R > VPAC1R > VPAC2R |
| VIP |
10-50 |
VPAC1R/VPAC2R > PAC1R |
| Maxadilan |
0.5-2 |
PAC1R selective |
- Hypothalamus: Suprachiasmatic nucleus (SCN), paraventricular nucleus (PVN), arcuate nucleus
- Hippocampus: CA1-CA3 pyramidal neurons, dentate gyrus
- Cerebral Cortex: Layers II-III, V-VI pyramidal neurons
- Amygdala: Central nucleus, basolateral complex
- Thalamus: Paraventricular nucleus, reuniens nucleus
- Brainstem: Locus coeruleus, dorsal raphe
- Glutamatergic neurons: High PAC1R expression
- GABAergic neurons: Moderate expression
- Dopaminergic neurons (VTA, SNc): Important for reward circuitry
- Cholinergic neurons (basal forebrain): Memory-related expression
PAC1R activates multiple intracellular cascades:
-
AC → cAMP → PKA: Major pathway
- CREB phosphorylation
- Gene transcription
- Synaptic plasticity
-
PLC → DAG/IP3 → PKC: Secondary pathway
- Calcium release
- Membrane depolarization
- Exocytosis
-
MAPK/ERK pathway: Long-term effects
- Cell survival
- Differentiation
- Neuroprotection
-
PI3K/Akt pathway: Anti-apoptotic
- Mitochondrial protection
- Autophagy regulation
PAC1R is a key neuroprotective receptor:
- Anti-apoptotic signaling: Blocks caspase activation
- Oxidative stress reduction: Increases antioxidant enzymes
- Mitochondrial protection: Maintains membrane potential
- Autophagy regulation: Promotes healthy protein turnover
- LTP enhancement: PACAP strengthens synaptic connections
- Learning and memory: Critical for hippocampal plasticity
- Long-term depression (LTD): Modulates synaptic weakening
- SCN function: PACAP synchronizes circadian clocks
- Light entrainment: PACAP mediates photic entrainment
- Sleep-wake cycles: Affects arousal states
- HPA axis modulation: Regulates cortisol release
- Anxiety behaviors: Anxiogenic and anxiolytic effects
- Neuroendocrine function: Connects stress to metabolism
- Neuroprotection: PACAP reduces amyloid-β toxicity
- Tau pathology: Modulates tau phosphorylation
- Synaptic function: Preserves synaptic plasticity
- Cholinergic system: Protects basal forebrain cholinergic neurons
Therapeutic potential:
- PACAP analogs for AD treatment
- Gene therapy approaches
- Peptide delivery across BBB
- Dopaminergic protection: PACAP protects SNc neurons
- Mitochondrial function: Improves complex I activity
- Alpha-synuclein: May reduce aggregation
- Neuroinflammation: Anti-inflammatory effects
- Motor neuron protection: PACAP reduces excitotoxicity
- Glial modulation: Affects microglia activation
- Slows disease progression: In animal models
¶ Stroke and Brain Injury
- Ischemic protection: Reduces infarct size
- Traumatic brain injury: Improves functional recovery
- Blood-brain barrier: Maintains BBB integrity
- Maxadilan: PAC1R-selective agonist
- PACAP-38: Natural neuroprotective peptide
- Novel analogs: BBB-penetrant compounds in development
- Phase I trials for stroke (completed)
- Phase II for AD (ongoing)
- Orphan drug status for ALS
- BBB penetration: Limited by peptide nature
- Peptidase degradation: Short half-life
- Receptor desensitization: Downregulation with chronic use
- ADCYAP1R1 knockout mice
- siRNA/shRNA knockdown
- CRISPR gene editing
- Whole-cell patch clamp
- Field potential recordings
- Calcium imaging
- Morris water maze
- Open field
- Circadian activity monitoring
- PAC1 receptor in neuroprotection (2020)
- PACAP and Alzheimer's disease (2021)
- PAC1R and circadian rhythm (2019)
- PACAP in Parkinson's disease (2022)
- PAC1R signaling mechanisms (2021)
- Therapeutic potential of PACAP (2023)
- PACAP and synaptic plasticity (2020)
- PAC1R knockout studies (2018)